Position

Professor of Paediatric Medicines Research

Director of Centre for Paediatric Pharmacy Research

Areas of Expertise

Paediatric Pharmacoepidemiology and Paediatric Psychopharmacology

Biography

Professor Ian Wong qualified as a pharmacist in 1992 and worked at the former Medicines Control Agency in the Yellow Card system between 1992 and 1993. He then started his research career in medication safety. Professor Wong took up a research pharmacist post at the David Lewis Centre for Epilepsy to investigate the safety of new antiepileptic drugs between 1994 and 1997. He was awarded his PhD from Manchester Medical School in 1998 for his work at the David Lewis Centre.

In 1997, Professor Wong took up a Lecturer in Pharmacy Practice post at the University of Bradford and was promoted to Senior Lecturer in 2001.

In 2002, Professor Wong moved to The School of Pharmacy, University of London to set up the Centre for Paediatric Pharmacy Research. He was awarded a Department of Health Public Health Career Scientist Award in 2002; Professor Wong is the only pharmacist to date to have received such an award. Professor Wong also received the Chemist and Druggist's Pharmacy Practice Research Medal 2004 for his research in paediatric medicines. He has received research grants from the UK Medical Research Council, UK Engineering and Physical Science Research Council, UK Economic and Science Research Council, Department of Health in England, European Commissioners and the pharmaceutical industry.

He has been an advisor to the Department of Health, World Health Organisation, European Medicines Agency and the pharmaceutical industry. Professor Wong is the Chair of the Pharmacy and Pharmacology Clinical Studies Group of the UK Medicines for Children Research Network. He is also the chair of the Long-term Effects of Psychotropic Medication in Children Research Group of the UK Mental Health Research Network.

Hsia Y, Neubert A, Sturkenboom MC, Murray ML, Verhamme KM, Sen F, Giaquinto C, Ceci A, Wong IC; on behalf of the TEDDY Network of Excellence. Comparison of antiepileptic drug prescribing in children in three European countries. Epilepsia 2009 Oct 8. [Epub ahead of print]

McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC. Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the general practice research database. Drug Saf 2009;32(11):1089-96.

McCarthy S, Asherson P, Coghill D, Hollis C, Murray M, Potts L, Sayal K, de Soysa R, Taylor E, Williams T, Wong ICK. Trends in prescribing prevalence and cessation of ADHD drug treatment among adolescents and young adults in the U.K. British Journal of Psychiatry 2009;194(3):273-7.

Rani FA, Byrne PJ, Murray ML, Carter P, Wong IC. Paediatric Atypical Antipsychotic Monitoring Safety (PAMS) Study: Pilot Study in Children and Adolescents in Secondary- and Tertiary-Care Settings. Drug Saf 2009;32(4):325-33.

Ackers R, Besag FMC, Wade A, Murray ML, Wong ICK. Changing trends in antiepileptic drug prescribing in girls of child-bearing potential. Arch Dis Child 2009;94(6):443-7

Sturkenboom MC, Verhamme KMC, Nicolosi A, Murray ML, Neubert A, Caudri D, Picelli G, Sen EF, Giaquinto C, Baiardi P, Felisi MG, Ceci A, Wong ICK, TEDDY European Network of Excellence. Drug use in children: cohort study in three European countries. British Medical Journal. 2008;337:a2245. doi: 10.1136/bmj.a2245.

Rani F, Murray M, Byrne P, Wong ICK. Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics 2008;121(5):1002-9.